|
FE first-quarter 2025 results are expected to benefit from improved service reliability. Yet, severe storms might have offset some positives.
|
|
|
AZN's key medicines, mainly cancer drugs, Lynparza, Tagrisso and Imfinzi, are expected to have driven the company's top line.
|
|
|
MainStreet Bank (MNSB) delivered earnings and revenue surprises of 19.05% and 1.39%, respectively, for the quarter ended March 2025. Do the numbers hold clues to what lies ahead for the stock?
|
|
|
TYL's Q1 results are likely to reflect benefits from robust demand for SaaS solutions as the public sector shifts from on-premise to cloud-based systems.
|
|
|
Universal Technical (UTI) could produce exceptional returns because of its solid growth attributes.
|
|
|
MasTec (MTZ) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.
|
|
|
Dividends are one of the best benefits to being a shareholder, but finding a great dividend stock is no easy task. Does NatWest Group (NWG) have what it takes? Let's find out.
|
|
|
Gentex (GNTX) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
|
|
|
The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.
|
|
|
Recently, Zacks.com users have been paying close attention to IBM (IBM). This makes it worthwhile to examine what the stock has in store.
|
|
Search Other Sites